A phase II study of bryostatin 1 in metastatic malignant melanoma

British Journal of Cancer

Volumn 78, Issue 10, 1998, Pages 1337-1341

  Propper, D J ^a   Macaulay, V ^a   O'Byrne, K J ^a   Braybrooke, J P ^a   Wilner, S M ^a   Ganesan, T S ^a   Talbot, D C ^a   Harris, A L ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Bryostatin 1; Malignant melanoma; Protein kinase C inhibitors

Indexed keywords

ALCOHOL; BRYOSTATIN 1; DILUENT; MACROGOL; POLYSORBATE 80;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FATIGUE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; MYALGIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; VOMITING;

EID: 0031760304     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.680     Document Type: Article

References (40)